Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
Details for Australian Patent Application No. 2006320654 (hide)
International Classifications
Event Publications
12 June 2008 PCT application entered the National Phase
PCT publication WO2007/064696 Priority application(s): WO2007/064696
27 October 2011 Assignment before Grant
Nevada Cancer Institute The application has been assigned to Ma, Yupo
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006320655-Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
2006320646-Prepregs and cured in place solid surfaces prepared therefrom
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser